![](/img/cover-not-exists.png)
Six months’ treatment with MIV-711, a novel Cathepsin K inhibitor induces osteoarthritis structure modification: results from a randomized double-blind placebo-controlled phase IIA trial
Conaghan, P.G., Bowes, M.A., Kingsbury, S.R., Brett, A., Guillard, G., Tunblad, K., Rizoska, B., Larsson, T., Holmgren, Å., Manninen, A., Göhlin, K., Heber, W., Graham, P., Jansson, Å., Wadell, C., BeVolume:
26
Language:
english
Journal:
Osteoarthritis and Cartilage
DOI:
10.1016/j.joca.2018.02.066
Date:
April, 2018
File:
PDF, 258 KB
english, 2018